ImmunoGen Message Board - Msg: 33969790

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	8/21/2022 1:49:40 PM
	Read Replies (1) of 5665

For the last few months I've been adding shares by first buying cheap option calls, often with a month or less to expiration. With IMGN on the rise approaching approval of MIRV and other news later in the year those calls were well in the money by expiration, my available margin funds had grown well over the cost of the shares, and I choose to add the shares rather than simply taking a profit that was at least a 5 banger on the calls. I haven't spent much money in buying the calls, normally about $.15 a share for shares substantially out of the money. If on expiration the calls are over $.50 cents in the money the least I have is better than a triple gain, more importantly my buy power is up far more than what I'm intending to purchase. If you agree with me that by the time we gain approval, which I believe could come in October or November, we'll be approaching double digit share prices and that we'll end the year in double digits, you'll see where investing a few hundred on cheap calls could be worth many thousands near term, and tens of thousands over time Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next